| Editorial |
|
| Psychopharmacology of schizophrenia: The future looks bleak |
|
 |
|
| Chittaranjan Andrade, Rajiv Radhakrishnan, Praveen P Fernandes |
|
| Introduction: More than half a century after the introduction of effective pharmacotherapy for the illness, in most patients schizophrenia remains a chronic, relapsing condition with poor long-... |
|
| [Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub] |
|
|
| Editorial |
|
| The future of schizophrenia pharmacotherapeutics: Not so bleak |
|
 |
|
| William T Carpenter |
|
| Chlorpromazine efficacy in schizophrenia was observed 60 years ago. Advances in pharmacotherapy of this disorder have been modest with effectiveness still limited to the psychosis psychopathology and ... |
|
| [Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub] |
